1. Home
  2. CYTK vs AWI Comparison

CYTK vs AWI Comparison

Compare CYTK & AWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • AWI
  • Stock Information
  • Founded
  • CYTK 1997
  • AWI 1860
  • Country
  • CYTK United States
  • AWI United States
  • Employees
  • CYTK N/A
  • AWI N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • AWI Plastic Products
  • Sector
  • CYTK Health Care
  • AWI Industrials
  • Exchange
  • CYTK Nasdaq
  • AWI Nasdaq
  • Market Cap
  • CYTK 5.6B
  • AWI 5.7B
  • IPO Year
  • CYTK 2004
  • AWI 2006
  • Fundamental
  • Price
  • CYTK $32.00
  • AWI $155.03
  • Analyst Decision
  • CYTK Buy
  • AWI Buy
  • Analyst Count
  • CYTK 15
  • AWI 7
  • Target Price
  • CYTK $73.71
  • AWI $157.57
  • AVG Volume (30 Days)
  • CYTK 2.0M
  • AWI 221.7K
  • Earning Date
  • CYTK 05-06-2025
  • AWI 07-29-2025
  • Dividend Yield
  • CYTK N/A
  • AWI 0.80%
  • EPS Growth
  • CYTK N/A
  • AWI 17.43
  • EPS
  • CYTK N/A
  • AWI 6.24
  • Revenue
  • CYTK $19,218,000.00
  • AWI $1,502,100,000.00
  • Revenue This Year
  • CYTK $24.01
  • AWI $11.64
  • Revenue Next Year
  • CYTK $698.33
  • AWI $6.01
  • P/E Ratio
  • CYTK N/A
  • AWI $24.69
  • Revenue Growth
  • CYTK 412.21
  • AWI 14.55
  • 52 Week Low
  • CYTK $29.31
  • AWI $110.68
  • 52 Week High
  • CYTK $61.38
  • AWI $164.40
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.20
  • AWI 56.52
  • Support Level
  • CYTK $30.02
  • AWI $152.12
  • Resistance Level
  • CYTK $31.27
  • AWI $159.43
  • Average True Range (ATR)
  • CYTK 1.32
  • AWI 2.64
  • MACD
  • CYTK 0.38
  • AWI -0.86
  • Stochastic Oscillator
  • CYTK 72.12
  • AWI 35.76

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AWI Armstrong World Industries Inc

Armstrong World Industries Inc. designs, innovates, and manufactures ceiling and wall solutions in the Americas. The company manufactures and sources products made of numerous materials, including mineral fiber, fiberglass, metal, felt, wood, resin, wood fiber, and glass-reinforced-gypsum. It also manufactures ceiling suspension system (grid) products through a joint venture with Worthington Industries, Inc., called Worthington Armstrong Venture (WAVE). The company's reportable operating segments include Mineral Fiber, Architectural Specialties, and Unallocated Corporate. A majority of its revenue is generated from the Mineral Fiber segment, which produces suspended mineral fiber and fiberglass ceiling systems. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: